Left Ventricular Noncompaction: A Patient Guide
At a Glance
Left ventricular noncompaction (LVNC) is a spongy-looking pattern in the heart’s main pumping chamber that may be harmless or linked to heart problems. Risk depends more on pumping strength, scarring, rhythm, and family history than on appearance alone.
Left Ventricular Noncompaction (LVNC) is a unique condition where the muscle of the heart’s main pumping chamber appears “spongy” or “honeycombed” on a medical scan rather than smooth and solid [1]. For many years, this was viewed as a rare and inherently dangerous disease. However, as imaging technology has improved, doctors are finding this “spongy” appearance—known as hypertrabeculation—in a much wider range of people, including healthy athletes and pregnant women [2]. This shift has led the medical community to move away from viewing LVNC as a single disease, instead seeing it as a physical trait that can range from a harmless anatomical variation to a condition that requires active management [2][3].
While the visual appearance of the heart is what often leads to the diagnosis, it is not actually the most important factor in your long-term health. The “sponginess” itself—the depth or number of those muscle bundles—does not accurately predict how you will feel or what your risks are [4]. Instead, your prognosis is determined by important risk markers: how well your heart is functioning, its pumping strength (ejection fraction or EF), the presence of any microscopic scarring (fibrosis) within the muscle wall [3][5], as well as your family history, genetics, and heart rhythm. If your heart pumps normally, shows no signs of scarring or enlargement, and you have no concerning arrhythmias or family history, your outlook is often very favorable and similar to that of the general population [3][6]. However, risk is never zero, and individualized follow-up is necessary.
For those who do require treatment, medical care focuses on three primary concerns: supporting the heart’s pumping function to prevent heart failure, monitoring for irregular heart rhythms, and reducing the risk of blood clots [7]. These complications only occur in a subset of patients, and modern treatments—including a combination of evidence-based medications and, in some cases, protective devices—are highly effective at managing these risks [8][9]. Because LVNC can be an inherited trait or associated with genetic mutations, your diagnosis also serves as a valuable health signal for your family, as the genetics of a “spongy” heart overlap heavily with other common heart conditions [10][11].
Living with LVNC means shifting your focus from the dramatic look of the heart on a screen to the practical reality of how your heart performs. This guide is designed to help you navigate that shift, moving past the intimidating “noncompaction” label so you can partner with your care team to monitor what truly matters. By understanding your specific heart function and risk profile, you can take an active role in a management plan that is tailored to your life, not just your imaging reports [12].
Urgent Care Warning
Please seek emergency medical help immediately if you experience:
- Severe or rapidly worsening shortness of breath
- Sudden or unexplained chest pain
- Fainting, passing out, or near-fainting
- Sustained rapid palpitations (your heart racing uncontrollably)
- New neurologic symptoms (like one-sided weakness, slurred speech, or facial drooping)
- Severe bleeding or black/bloody stools
- Repeated shocks from an implanted defibrillator (ICD)
Call your cardiology team promptly if you experience rapid fluid-weight gain (e.g., 2-3 lbs in a day) or new swelling in your legs.
In this guide
6 chapters
Understanding Left Ventricular Noncompaction
Learn what left ventricular noncompaction (LVNC) means, how heart function and scarring affect risk, and how doctors monitor heart pumping and rhythm problems.
How Doctors Diagnose a Spongy Heart
Learn how left ventricular noncompaction is diagnosed using Jenni and Petersen criteria, imaging ratios, LGE scarring, and heart function to assess risk.
Managing Heart Failure When You Have LVNC
Learn how heart failure with reduced ejection fraction is treated in LVNC, including four-pillar medicines, diuretics, dose titration, and safety monitoring.
Heart Rhythms and the Role of an ICD
Learn how left ventricular noncompaction (LVNC) relates to dangerous rhythms and how EF, MRI scarring, monitoring, and symptoms guide ICD decisions and safety.
Preventing Blood Clots in LVNC
Learn when left ventricular noncompaction (LVNC) may require blood thinners, how AFib and low EF affect stroke risk, and key monitoring and safety steps.
Genetics and Your Family's Heart Health
Learn how left ventricular noncompaction (LVNC) can run in families, when genetic testing helps, and why relatives may need repeat heart screening over time.
Common questions in this guide
Does a spongy-looking heart always mean I have a dangerous condition?
What determines my risk if I have LVNC?
What tests are used to monitor LVNC?
Does everyone with LVNC need treatment?
Should my relatives be checked for LVNC?
When should I seek emergency help with LVNC?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Left ventricular noncompaction.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my imaging, do I have 'isolated' LVNC or is my heart's pumping function also affected?
- 2.How does the modern view of LVNC as a 'phenotypic trait' change how you will manage my care?
- 3.What is my ejection fraction, and is it stable compared to previous tests?
- 4.Do I have any signs of scarring (LGE) on my cardiac MRI that would increase my risk of heart rhythm issues?
- 5.Given my diagnosis, which of my family members should be screened with an echocardiogram?
References
References (12)
- 1
Left Ventricular Non-Compaction: Evolving Concepts.
Pittorru R, De Lazzari M, Migliore F, et al.
Journal of clinical medicine 2024; (13(19)) doi:10.3390/jcm13195674.
PMID: 39407735 - 2
What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question.
Di Lisi D, Macaione F, Damiani F, et al.
Current problems in cardiology 2024; (49(11)):102787 doi:10.1016/j.cpcardiol.2024.102787.
PMID: 39137881 - 3
Long-Term Survival of Patients With Left Ventricular Noncompaction.
Vaidya VR, Lyle M, Miranda WR, et al.
Journal of the American Heart Association 2021; (10(2)):e015563 doi:10.1161/JAHA.119.015563.
PMID: 33441029 - 4
Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.
Aung N, Doimo S, Ricci F, et al.
Circulation. Cardiovascular imaging 2020; (13(1)):e009712 doi:10.1161/CIRCIMAGING.119.009712.
PMID: 31959004 - 5
Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.
Andreini D, Pontone G, Bogaert J, et al.
Journal of the American College of Cardiology 2016; (68(20)):2166-2181 doi:10.1016/j.jacc.2016.08.053.
PMID: 27855806 - 6
Prognosis of Adults With Isolated Left Ventricular Non-Compaction: Results of a Prospective Multicentric Study.
Gerard H, Iline N, Martel H, et al.
Frontiers in cardiovascular medicine 2022; (9()):856160 doi:10.3389/fcvm.2022.856160.
PMID: 35586644 - 7
Predictors of life-threatening events in adult patients with left ventricular noncompaction.
Blagova OV, Varionchik NV, Pavlenko EV, et al.
World journal of cardiology 2025; (17(12)):112126 doi:10.4330/wjc.v17.i12.112126.
PMID: 41479993 - 8
Guidelines for treating heart failure.
Kittleson MM
Trends in cardiovascular medicine 2025; (35(3)):141-150 doi:10.1016/j.tcm.2024.10.002.
PMID: 39442740 - 9
The Relevance of Preventive Implantable Cardioverter-Defibrillators (ICDs) in Non-Ischemic Cardiomyopathy in the Presence of Effective Quadruple Therapy for Heart Failure: A Review of Contemporary Medical Literature.
Obi MF, Namireddy V, Reinberg Palmar MA, et al.
Cureus 2023; (15(4)):e38268 doi:10.7759/cureus.38268.
PMID: 37255904 - 10
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.
Mazzarotto F, Hawley MH, Beltrami M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(5)):856-864 doi:10.1038/s41436-020-01049-x.
PMID: 33500567 - 11
Loss of Function Mutations in NNT Are Associated With Left Ventricular Noncompaction.
Bainbridge MN, Davis EE, Choi WY, et al.
Circulation. Cardiovascular genetics 2015; (8(4)):544-52 doi:10.1161/CIRCGENETICS.115.001026.
PMID: 26025024 - 12
Left Ventricular Non-Compaction in Athletes: To Play or Not to Play.
Coris EE, Moran BK, De Cuba R, et al.
Sports medicine (Auckland, N.Z.) 2016; (46(9)):1249-59 doi:10.1007/s40279-016-0512-2.
PMID: 27002622
This page is for informational purposes only and does not constitute medical advice. Discuss your imaging, heart function, rhythm, and family screening needs with your cardiology team.